Cognitive status of patients judged fit for discharge from the post-anaesthesia care unit after general anaesthesia: a randomized comparison between desflurane and propofol.


Journal

BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535

Informations de publication

Date de publication:
11 03 2021
Historique:
received: 20 11 2020
accepted: 22 02 2021
entrez: 12 3 2021
pubmed: 13 3 2021
medline: 8 1 2022
Statut: epublish

Résumé

The Aldrete's score is used to determine when a patient can safely leave the Post-Anaesthesia Care Unit (PACU) and be transferred to the surgical ward. The Aldrete score is based on the evaluation of vital signs and consciousness. Cognitive functions according to the anaesthetic strategy at the time the patient is judged fit for discharge from the PACU (Aldrete's score ≥ 9) have not been previously studied. The aim of this trial was to assess the cognitive status of inpatients emerging either from desflurane or propofol anaesthesia, at the time of PACU discharge (Aldrete score ≥ 9). Sixty adult patients scheduled for hip or knee arthroplasty under general anaesthesia were randomly allocated to receive either desflurane or propofol anaesthesia. Patients were evaluated the day before surgery using Digit Symbol Substitution Test (DSST), Stroop Color Test and Verbal Learning Test. After surgery, the Aldrete score was checked every 5 min until reaching a score ≥ 9. At this time, the same battery of cognitive tests was applied. Each test was evaluated separately. Cognitive status was reported using a combined Z score pooling together the results of all 3 cognitive tests. Among the 3 tests, only DSST was significantly reduced at Aldrete Score ≥ 9 in the Desflurane group. Combined Z-scores at Aldrete Score ≥ 9 were (in medians [interquartils]): - 0.2 [- 1.2;+ 0.6] and - 0.4 [- 1.1;+ 0.4] for desflurane and propofol groups respectively (P = 0.62). Cognitive dysfunction at Aldrete score ≥ 9 was observed in 3 patients in the Propofol group and in 2 patients in the Desflurane group) (P = 0.93). No difference was observed in cognitive status at Aldrete score ≥ 9 between desflurane and propofol anaesthesia. Although approximately 10% of patients still had cognitive dysfunctions, an Aldrete score ≥ 9 was associated with satisfactory cognitive function recovery in the majority of the patients after lower limb arthroplasty surgery under general anaesthesia. Clinical Trials identifier NTC02036736 .

Sections du résumé

BACKGROUND
The Aldrete's score is used to determine when a patient can safely leave the Post-Anaesthesia Care Unit (PACU) and be transferred to the surgical ward. The Aldrete score is based on the evaluation of vital signs and consciousness. Cognitive functions according to the anaesthetic strategy at the time the patient is judged fit for discharge from the PACU (Aldrete's score ≥ 9) have not been previously studied. The aim of this trial was to assess the cognitive status of inpatients emerging either from desflurane or propofol anaesthesia, at the time of PACU discharge (Aldrete score ≥ 9).
METHODS
Sixty adult patients scheduled for hip or knee arthroplasty under general anaesthesia were randomly allocated to receive either desflurane or propofol anaesthesia. Patients were evaluated the day before surgery using Digit Symbol Substitution Test (DSST), Stroop Color Test and Verbal Learning Test. After surgery, the Aldrete score was checked every 5 min until reaching a score ≥ 9. At this time, the same battery of cognitive tests was applied. Each test was evaluated separately. Cognitive status was reported using a combined Z score pooling together the results of all 3 cognitive tests.
RESULTS
Among the 3 tests, only DSST was significantly reduced at Aldrete Score ≥ 9 in the Desflurane group. Combined Z-scores at Aldrete Score ≥ 9 were (in medians [interquartils]): - 0.2 [- 1.2;+ 0.6] and - 0.4 [- 1.1;+ 0.4] for desflurane and propofol groups respectively (P = 0.62). Cognitive dysfunction at Aldrete score ≥ 9 was observed in 3 patients in the Propofol group and in 2 patients in the Desflurane group) (P = 0.93).
CONCLUSION
No difference was observed in cognitive status at Aldrete score ≥ 9 between desflurane and propofol anaesthesia. Although approximately 10% of patients still had cognitive dysfunctions, an Aldrete score ≥ 9 was associated with satisfactory cognitive function recovery in the majority of the patients after lower limb arthroplasty surgery under general anaesthesia.
TRIAL REGISTRATION
Clinical Trials identifier NTC02036736 .

Identifiants

pubmed: 33706698
doi: 10.1186/s12871-021-01287-9
pii: 10.1186/s12871-021-01287-9
pmc: PMC7948375
doi:

Substances chimiques

Anesthetics, Inhalation 0
Anesthetics, Intravenous 0
Desflurane CRS35BZ94Q
Propofol YI7VU623SF

Types de publication

Comparative Study Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

76

Références

Anesthesiology. 2018 Dec;129(6):1063-1069
pubmed: 30273268
Anesthesiology. 2015 Jun;122(6):1224-34
pubmed: 25859906
Br J Clin Pharmacol. 1980 Sep;10(3):189-209
pubmed: 7002180
Anesthesiology. 2007 Mar;106(3):572-90
pubmed: 17325517
Anesth Analg. 2011 May;112(5):1179-85
pubmed: 21474666
Exp Aging Res. 1993 Jul-Sep;19(3):209-24
pubmed: 8223823
Acta Anaesthesiol Scand. 2013 Nov;57(10):1308-12
pubmed: 24004001
Anaesth Intensive Care. 2018 Nov;46(6):596-600
pubmed: 30447669
Anesthesiology. 2018 Nov;129(5):872-879
pubmed: 30325806
Anaesthesia. 1989 Nov;44(11):889-92
pubmed: 2596654
Ann Intern Med. 2001 Apr 17;134(8):657-62
pubmed: 11304106
Anesth Analg. 2003 Mar;96(3):701-5, table of contents
pubmed: 12598249
J Clin Anesth. 2013 Sep;25(6):439-46
pubmed: 23965209
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Anesth Analg. 1996 Mar;82(3):445-51
pubmed: 8623940
Br J Anaesth. 2000 Jan;84(1):11-5
pubmed: 10740540
J Gen Psychol. 1985 Apr;112(2):201-10
pubmed: 4056765
Assessment. 2006 Mar;13(1):62-79
pubmed: 16443719
J Clin Anesth. 1995 Feb;7(1):89-91
pubmed: 7772368
Anesth Analg. 2004 Mar;98(3):632-41, table of contents
pubmed: 14980911
Pain. 2000 Mar;85(1-2):209-15
pubmed: 10692620
Anesthesiology. 2010 Oct;113(4):892-905
pubmed: 20601860
Acta Anaesthesiol Scand. 2001 Mar;45(3):275-89
pubmed: 11207462
Anesth Analg. 2005 Sep;101(3):688-96, table of contents
pubmed: 16115976
Anesthesiology. 2007 Mar;106(3):431-5
pubmed: 17325500
Anesth Analg. 1999 Sep;89(3):652-8
pubmed: 10475299
Anaesthesia. 2013 Mar;68(3):288-97
pubmed: 23384257
Anesth Analg. 1993 May;76(5):936-41
pubmed: 8484548
Anesth Analg. 2018 Aug;127(2):496-505
pubmed: 29889707
Anesthesiology. 1992 May;76(5):696-702
pubmed: 1575336
Br J Anaesth. 2018 May;120(5):999-1008
pubmed: 29661417
BMJ. 2011 Jul 20;343:d4331
pubmed: 21775401
Br J Anaesth. 2015 Sep;115(3):411-7
pubmed: 25540068
Anesthesiology. 1997 Nov;87(5):1082-8
pubmed: 9366460

Auteurs

Cyrille Robert (C)

Department of Anaesthesia and Critical Care, Clinique Mutualiste de Pessac, Pessac, France.

Anne Soulier (A)

Department of Anaesthesia and Critical Care, St-Antoine Hospital. Assistance Publique-Hôpitaux de Paris, 75012, Paris, France.

Didier Sciard (D)

Department of Anaesthesia, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, 75014, Paris, France.

Guillaume Dufour (G)

Department of Anaesthesia, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, 75014, Paris, France.

Corinne Alberti (C)

Unit of Clinical Epidemiology, Assistance Publique-Hôpitaux de Paris, CHU Robert Debré, University Paris Diderot, Sorbonne Paris-Cité, CIC-EC 1426 and, UMR-S 1123 ECEVE, 75019, Paris, France.

Priscilla Boizeau (P)

Unit of Clinical Epidemiology, Assistance Publique-Hôpitaux de Paris, CHU Robert Debré, University Paris Diderot, Sorbonne Paris-Cité, CIC-EC 1426 and, UMR-S 1123 ECEVE, 75019, Paris, France.

Marc Beaussier (M)

Department of Anaesthesia, Institut Mutualiste Montsouris, 42 Boulevard Jourdan, 75014, Paris, France. marc.beaussier@imm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH